HOME >> BIOLOGY >> NEWS
UC Berkeley biologist disputes current dogma that genetic mutation is the cause of cancer

Berkeley -- A University of California, Berkeley, scientist is challenging one of the central tenets of cancer research, that cancer results from a chance series of genetic mutations that drive a cell into wild, uncontrolled growth.

Molecular biologist Peter Duesberg, better known for his claim that the human immunodeficiency virus is not the cause of AIDS, contends that mutation is not the cause of cancer. Rather, he says, cancer results from disruption of the normal number of chromosomes in a cell, primarily duplication of one or more chromosomes.

Called aneuploidy, this type of chromosomal abnormality is found in nearly every solid cancer studied to date, but has always been considered a side effect of cancer, not the cause itself.

In a peer-reviewed article in the March 28 issue of the journal Proceedings of the National Academy of Sciences, Duesberg and his colleagues at UC Berkeley argue instead that aneuploidy is the primary cause of cancer and explains many aspects of cancer that the genetic mutation theory cannot.

For some 25 years, Duesberg has pointed out problems with the genetic mutation theory of cancer. Now that the theory has become almost dogma, he is ratcheting up his criticism and receiving support from numerous other scientists

"Peter won't let the field stand still, which is extremely important," said Avery A. Sandberg, chief editor of the journal Cancer Genetics and Cytogenetics. "Once scientists think of one theory as being the de facto theory, we're in great trouble."

If Duesberg is right, it would overthrow a theory that has dominated thinking for the past 15 years, guiding research and dictating how doctors detect and prevent cancer. One field that would feel the impact is cancer screening.

"Rather than looking for mutations in biopsied cells, we should look for aneuploidy as a sign of early cancer," said Duesberg, a professor of molecular and cell biology.

A group of physicians at UC San Francisco is now
'"/>

Contact: Robert Sanders
rls@pa.urel.berkeley.edu
510-643-6998
University of California - Berkeley
4-Apr-2000


Page: 1 2 3 4 5

Related biology news :

1. Landmark gene agreement announced by Samoan government and UC Berkeley for anti-AIDS drug Prostratin
2. Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
3. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
4. MSU group reviews Berkeley venture into brave new science funding world
5. UC Berkeley museum biologists to repeat 85-year-old Yosemite National Park wildlife survey
6. Berkeley scientists create first 3-D map of protein universe
7. UC Berkeley scientists detail neural circuit that lets eye detect directional motion
8. UC Berkeley, Joint Genome Institute target chloroplasts for clues to green plant evolution
9. Your brain is teaching your nose new tricks, say UC Berkeley researchers
10. UC Berkeley researchers are developing a microsized microscope that can peek inside living cells
11. Dietary supplements make old rats youthful, may help rejuvenate aging humans, according to UC Berkeley study

Post Your Comments:
(Date:10/16/2014)... have challenged conventional thinking on how the bowel lining ... for how bowel cancer starts. , The researchers produced ... regenerating the ,crypts, that are a feature of the ... in bowel cancer development, a controversial finding as scientists ... Using 3D imaging technologies, Dr Chin Wee Tan and ...
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... edge technologies including Wocket™, the Smart Wallet, at the ... FiRe is a leading global conference on the intersection ... by Mark Anderson , founder and publisher of ...
(Date:10/15/2014)... has admitted Johannes Gutenberg University Mainz (JGU) as ... hub continues to maintain a significant nationwide standing ... "The acceptance of Johannes Gutenberg University Mainz as ... milestone in the national and international competition for ... of Rhineland-Palatinate can be proud that Mainz University ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
(Date:10/25/2014)... , October 24, 2014 Investor-Edge ... (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... on these five companies can be accessed at: ... October 23, 2014, ended on a positive note as ...
(Date:10/25/2014)... , October 24, 2014 ... Markets ( http://www.researchandmarkets.com/research/t5t5pd/the_global_market ) has announced the addition ... Nanotubes, Graphene And Other 2-D Nanomaterials " ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,CNTs and graphene are ... known to man, with a performance-per-weight greater ...
(Date:10/22/2014)... , Oct. 22, 2014 Research ... the "Global DNA Diagnostics Market (Product types, ... Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ... 2020" report to their offering. ... (products, applications, techniques, end users and Geography) Global ...
(Date:10/22/2014)... The Americas Inorganic Refrigerants Market report ... Americas with analysis and forecast of revenue. , ... Refrigerants Market report, to get an idea of ... glimpse of the segmentation in the Americas inorganic ... and figures. , http://www.micromarketmonitor.com/market/americas-inorganic-refrigerants-4191654241.html , ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 4Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 2The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 3
Cached News: